The expert evidence indicated that co-administering MDR-TB and HCV treatments, as compared to delaying HCV treatment while treating MDR-TB alone, may yield several benefits.

The full-scale invasion of russia in February 2022 had a profound impact on various aspects of life in Ukraine, including healthcare and the fight against HIV and tuberculosis. The Global Fund conducted an assessment of the situation in Ukraine from the moment of the full-scale invasion until the beginning of 2023.

The exploration of a new intervention in linkage HIV-infected patients in treatment, known as MARTAS, which was implemented by our Institute in Ukraine, has been recognized as having the lowest level of risk of bias. This conclusion comes from a recently published systematic review and meta-analysis of linkage to HIV care interventions in the United States, Canada, and Ukraine over an eleven-year period.